Cargando…
Identification of glioma-associated antigen MUC 2-63 as CD44.
Monoclonal antibody MUC 2-63 recognises neurogenic tumours and has been used successfully for radioimaging human malignant gliomas. We now show that the MUC 2-63 antigen has the same tissue distribution and molecular weight range as the CD44 antigen and confirm the identity of these two molecules in...
Autores principales: | Romeijn, P., Lenthall, R., Stavrou, D., Melcher, D., Ladyman, H., Ritter, M. A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033549/ https://www.ncbi.nlm.nih.gov/pubmed/7524600 |
Ejemplares similares
-
Irradiation Alters the Expression of MUC1, CD44 and Hyaluronan in Oral Mucosal Epithelium
por: Kashyap, Bina, et al.
Publicado: (2022) -
Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance
por: Pothuraju, Ramesh, et al.
Publicado: (2020) -
p63 inhibits CD44(+)/CD24(−) cell proliferation and chemoresistance in papillary thyroid carcinoma cells
por: Guo, Jing-Jing, et al.
Publicado: (2017) -
Expression of CD44 and the survival in glioma: a meta-analysis
por: Wu, Gang, et al.
Publicado: (2020) -
CD44 expressed by myeloid cells promotes glioma invasion
por: Ivanova, Ekaterina L., et al.
Publicado: (2022)